BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10801041)

  • 1. Endogenous TGF-beta1 inhibits the growth and metastatic dissemination of rat oral carcinoma cell lines but enhances local bone resorption.
    Davies M; Prime SS; Stone AM; Huntley SP; Eveson JW; Paterson IC
    J Oral Pathol Med; 2000 May; 29(5):232-40. PubMed ID: 10801041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of autocrine TGF-beta 1 suppresses the growth of spindle epithelial cells in vitro and in vivo in the rat 4NQO model of oral carcinogenesis.
    Davies M; Prime SS; Stone AM; Heung YL; Huntley SP; Matthews JB; Eveson JW; Paterson IC
    Int J Cancer; 1997 Sep; 73(1):68-74. PubMed ID: 9334812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of differentiation of 4NQO-induced rat malignant oral keratinocytes correlates with metastatic dissemination and is associated with a reduced cellular response to TGF-beta1 and an altered receptor profile.
    Davies M; Paterson IC; Stone A; Huntley S; Patel V; Curtis R; Matthews JB; Pring M; Eveson JW; Prime SS
    J Oral Pathol Med; 1999 Oct; 28(9):397-405. PubMed ID: 10535362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGF-beta1 acts as a tumor suppressor of human malignant keratinocytes independently of Smad 4 expression and ligand-induced G(1) arrest.
    Paterson IC; Davies M; Stone A; Huntley S; Smith E; Pring M; Eveson JW; Robinson CM; Parkinson EK; Prime SS
    Oncogene; 2002 Feb; 21(10):1616-24. PubMed ID: 11896591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metastatic dissemination of human malignant oral keratinocyte cell lines following orthotopic transplantation reflects response to TGF-beta 1.
    Prime SS; Eveson JW; Stone AM; Huntley SP; Davies M; Paterson IC; Robinson CM
    J Pathol; 2004 Aug; 203(4):927-32. PubMed ID: 15258995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuated type II TGF-beta receptor signalling in human malignant oral keratinocytes induces a less differentiated and more aggressive phenotype that is associated with metastatic dissemination.
    Huntley SP; Davies M; Matthews JB; Thomas G; Marshall J; Robinson CM; Eveson JW; Paterson IC; Prime SS
    Int J Cancer; 2004 Jun; 110(2):170-6. PubMed ID: 15069677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor-β enhances invasion and metastasis in Ras-transfected human malignant epidermal keratinocytes.
    Davies M; Prime SS; Eveson JW; Price N; Ganapathy A; D'Mello A; Paterson IC
    Int J Exp Pathol; 2012 Apr; 93(2):148-56. PubMed ID: 22414291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of JunB in undifferentiated malignant rat oral keratinocytes enhances the malignant phenotype in vitro without altering cellular differentiation.
    Robinson CM; Prime SS; Huntley S; Stone AM; Davies M; Eveson JW; Paterson IC
    Int J Cancer; 2001 Mar; 91(5):625-30. PubMed ID: 11267971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor beta 1 (TGF beta 1) is an autocrine positive regulator of colon carcinoma U9 cells in vivo as shown by transfection of a TGF beta 1 antisense expression plasmid.
    Huang F; Newman E; Theodorescu D; Kerbel RS; Friedman E
    Cell Growth Differ; 1995 Dec; 6(12):1635-42. PubMed ID: 9019169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation of malignant oral rat keratinocytes reflects changes in EGF and TGF-beta receptor expression but not growth factor dependence.
    Game SM; Stone A; Matthews JB; Scully C; Prime SS
    Carcinogenesis; 1991 Mar; 12(3):409-16. PubMed ID: 1849051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased expression of TGF-beta cell surface receptors during progression of human oral squamous cell carcinoma.
    Paterson IC; Matthews JB; Huntley S; Robinson CM; Fahey M; Parkinson EK; Prime SS
    J Pathol; 2001 Apr; 193(4):458-67. PubMed ID: 11276004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumour progression in experimental oral carcinogenesis is associated with changes in EGF and TGF-beta receptor expression and altered responses to these growth factors.
    Game SM; Stone A; Scully C; Prime SS
    Carcinogenesis; 1990 Jun; 11(6):965-73. PubMed ID: 2161297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autocrine production of TGF-alpha and TGF-beta during tumour progression of rat oral keratinocytes.
    Donnelly MJ; Patel V; Yeudall WA; Game SM; Scully C; Prime SS
    Carcinogenesis; 1993 May; 14(5):981-5. PubMed ID: 8504493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parathyroid hormone-related protein and bone metastases.
    Guise TA
    Cancer; 1997 Oct; 80(8 Suppl):1572-80. PubMed ID: 9362424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGF-beta promotes the establishment of renal cell carcinoma bone metastasis.
    Kominsky SL; Doucet M; Brady K; Weber KL
    J Bone Miner Res; 2007 Jan; 22(1):37-44. PubMed ID: 17032147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contextual effects of transforming growth factor beta on the tumorigenicity of human colon carcinoma cells.
    Ye SC; Foster JM; Li W; Liang J; Zborowska E; Venkateswarlu S; Gong J; Brattain MG; Willson JK
    Cancer Res; 1999 Sep; 59(18):4725-31. PubMed ID: 10493532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consequences of altered TGF-beta expression and responsiveness in breast cancer: evidence for autocrine and paracrine effects.
    Tobin SW; Douville K; Benbow U; Brinckerhoff CE; Memoli VA; Arrick BA
    Oncogene; 2002 Jan; 21(1):108-18. PubMed ID: 11791181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor beta1 is a target for the von Hippel-Lindau tumor suppressor and a critical growth factor for clear cell renal carcinoma.
    Ananth S; Knebelmann B; Grüning W; Dhanabal M; Walz G; Stillman IE; Sukhatme VP
    Cancer Res; 1999 May; 59(9):2210-6. PubMed ID: 10232610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Over-expression of TGF-beta1 in Smad4-deficient human oral carcinoma cells causes tumour regression in vivo by mechanisms that sensitize cells to apoptosis.
    Thavaraj S; Paterson IC; Hague A; Prime SS
    J Pathol; 2005 Jan; 205(1):14-20. PubMed ID: 15546158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of transforming growth factor beta type I receptor abolishes malignant phenotype of a rat bladder carcinoma cell line.
    Okamoto M; Oyasu R
    Cell Growth Differ; 1997 Aug; 8(8):921-6. PubMed ID: 9269901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.